Recombinant Human Transmembrane protein FLJ78588

Shipped with Ice Packs
In Stock

Description

TMEFF2/Tomoregulin-2: Detailed Analysis

TMEFF2 (transmembrane protein with an EGF-like and two Follistatin-like domains 2) is a type I transmembrane glycoprotein . Key features and functions include:

  • Structure: TMEFF2 contains two extracellular follistatin modules, an extracellular EGF-like domain, a transmembrane domain, and a short conserved cytoplasmic tail .

  • Expression and Tissue Distribution: TMEFF2 is expressed in a range of tissues, making it a potential biomarker and therapeutic target .

  • Functional Diversity: TMEFF2 functions include roles in metabolism, embryonic development, cytoskeletal binding, extracellular matrix binding, chromatin binding, interaction of RNA polymerase II with DNA, and neuronal development .

  • Ligand Binding: TMEFF2 binds and inhibits PDGF-AA and also binds amyloid-b protein, its precursor AbPP, and amyloid-b proteins AbPOs, suggesting a neuroprotective role in Alzheimer's disease .

  • Role in Cancer: Differential methylation of TMEFF2 is related to the response to therapy and survival outcomes in various cancers, including breast, prostate, lung, bladder, colon and rectal, gallbladder, renal, oesophageal, cardiac, stomach/gastric, ovarian, multiple myeloma, glioblastoma, and mesothelioma .

Recombinant Human TMEFF2 Protein

Recombinant Human TMEFF2/Tomoregulin-2 His-tag Protein is produced with a C-terminal 10-His tag . Key aspects include:

  • Purity and Formulation: It is lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. Reconstitution should be done at 500 μg/mL in PBS .

  • Stability and Storage: The product is shipped at ambient temperature but should be stored immediately at the recommended temperature, using a manual defrost freezer to avoid repeated freeze-thaw cycles .

  • Scientific Data: When Recombinant Human PDGF-AA is immobilized, Recombinant Human TMEFF2/Tomoregulin-2 His-tag Protein binds with an ED50 of 0.750‑4.50 μg/mL .

Functional Studies and Applications

TMEFF2 has diverse functions and potential applications:

  • Inhibition of Cell Proliferation: TMEFF2 inhibits the proliferation of DU145 and PC3 prostate cancer cell lines .

  • Neuroprotection: TMEFF2's interaction with amyloid-b proteins suggests a neuroprotective role in Alzheimer's disease .

  • Cancer Research: TMEFF2 is considered a possible biomarker and/or therapeutic target due to its differential methylation in various cancers .

Data Tables

The following tables present data related to TMEFF2, based on the analyzed articles:

Table 2: TMEFF2 Binding Affinity

LigandED50 (μg/mL)
Recombinant Human PDGF-AA0.750-4.50

Research Findings

  • Meta-Analysis of Protein Intake on Athletic Performance: While not directly related to TMEFF2, a meta-analysis investigated the impact of protein intake on athletic performance, showing that protein intake provides modest benefits to athletes, particularly in enhancing endurance . Subgroup analysis indicated statistically significant improvement in endurance performance with protein supplementation .

  • CDC42 GTPases and Cancer Treatment: Research on CDC42 GTPases (RHOJ, CDC42, and RHOQ) has identified compounds that block their interaction with downstream effectors, potentially inhibiting tumor growth, angiogenesis, and metastasis .

Multi-Pass Transmembrane Virus-Like Particle (VLP) Proteins

  • VLP Proteins in Immunotherapy: Virus-like particles (VLPs) displaying membrane proteins are utilized in cancer immunotherapy . Sino Biological offers VLP proteins like GPRC5D, Claudin 6, Claudin 18, and SSTR2 for researchers in this field . VLPs display membrane proteins in their full natural conformation, making them suitable for immunization and antibody screening .

Implications for Alzheimer's Disease

  • Amyloid Precursor Protein (APP) and Alzheimer's: Research indicates a conserved role for APP in controlling age-dependent proteostasis, with relevance to Alzheimer's disease . Studies on Drosophila ortholog of APP, Appl, reveal its role in regulating autophagy through TGFβ signaling, impacting cellular pathways like translation, mitochondrial function, and lipid metabolism .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a useful reference.
Shelf Life
Shelf life depends on several factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-168
Protein Length
full length protein
Target Protein Sequence
MPKGWGVRSSTFLPLWLPVKIELHQVQFHSSSQMIFSTLRSELYKLLALCQHAVVPMGKF LGKTKTQSQGQVVIFSEKGKAIIYLSLPRTVPIYTCIFSQSVGCLFILLIISLNFLLFIY FIETDLIMLPRVILDLLASSDPPTLVSQSAGITDVNYHTQSTCRRFSV
Uniprot No.

Q&A

What is the structural characterization of human transmembrane protein FLJ78588?

Recombinant human transmembrane protein FLJ78588 is a relatively small protein consisting of 168 amino acids in its full-length form . Like other transmembrane proteins, it contains hydrophobic domains that anchor it within the cell membrane. Current structural data suggests it contains multiple transmembrane domains, though high-resolution structural information remains limited compared to better-characterized transmembrane proteins.

To characterize the structure, researchers typically employ a combination of computational prediction algorithms to identify transmembrane regions and experimental approaches such as circular dichroism spectroscopy to determine secondary structure elements. For definitive structural characterization, techniques like X-ray crystallography or cryo-electron microscopy would be required, though these present significant technical challenges for membrane proteins due to their hydrophobic nature and requirement for detergent or lipid environments.

What expression systems are optimal for producing recombinant FLJ78588?

For research requiring properly folded and post-translationally modified protein, alternative expression systems should be considered:

Expression SystemAdvantagesDisadvantagesBest For
E. coliHigh yield, inexpensive, rapidLimited post-translational modifications, inclusion body formationStructural studies after refolding, antibody production
Insect cellsBetter folding, some post-translational modificationsModerate cost, more complex cultureFunctional studies, protein-protein interaction analysis
Mammalian cellsNative folding and modificationsHigher cost, lower yield, time-consumingFunctional studies requiring authentic structure
Cell-free systemsRapid, direct incorporation of modified amino acidsExpensive, potentially lower yieldSpecialized applications requiring controlled modifications

Selection of the optimal system depends on the specific research questions and downstream applications for the recombinant protein.

How can researchers effectively study protein-protein interactions involving FLJ78588?

Studying protein-protein interactions for transmembrane proteins like FLJ78588 requires specialized approaches to maintain native conformation and functionality. While specific interaction partners for FLJ78588 have not been well-characterized in the literature, several methodologies can be applied based on approaches used for other transmembrane proteins.

Proteomic approaches similar to those used in multiregional profiling of brain transmembrane proteomes can be adapted for FLJ78588 . These could include:

  • Co-immunoprecipitation followed by mass spectrometry to identify interacting partners, using detergent conditions that preserve membrane protein interactions.

  • Proximity-based labeling methods such as BioID or APEX, which can capture transient or weak interactions in the native cellular environment.

  • Proteomics-derived co-expression analysis, which has successfully revealed novel GPCR interactions in brain tissue, could be applied to identify potential FLJ78588 interaction partners .

  • Proximity ligation assays (PLA) to confirm close physical distribution between FLJ78588 and candidate interacting proteins in cellular contexts, similar to validation approaches used for CB1 and FLRT3 interactions .

It's worth noting that protein-protein interaction networks derived from co-expression data have successfully predicted novel interactions for other transmembrane proteins, with PCC (Pearson Correlation Coefficient) values above 0.9 providing high confidence predictions .

What approaches can be used to investigate the spatial distribution and trafficking of FLJ78588 in different cell types?

Understanding the subcellular localization and trafficking patterns of FLJ78588 requires multimodal imaging approaches. Based on studies of other transmembrane proteins, researchers can consider:

  • Multi-color immunofluorescence microscopy using validated antibodies against FLJ78588 and markers for different cellular compartments to determine steady-state localization patterns.

  • Live-cell imaging with fluorescently tagged FLJ78588 to monitor dynamic trafficking events, though care must be taken to ensure tags don't interfere with trafficking signals.

  • Super-resolution microscopy techniques (STORM, PALM, STED) to resolve nanoscale distribution patterns beyond the diffraction limit of conventional microscopy.

  • Correlative light and electron microscopy (CLEM) for ultrastructural context of FLJ78588 localization.

Protein distribution patterns often differ markedly from mRNA distribution for transmembrane proteins, as observed in comprehensive brain region studies . This discrepancy highlights the importance of directly assessing protein localization rather than relying solely on transcriptomic data.

How should researchers design experiments to study the function of FLJ78588?

Designing rigorous experiments to elucidate FLJ78588 function requires careful consideration of variables and controls. Follow these systematic steps:

  • Define your variables clearly:

    • Independent variable: The factor you manipulate (e.g., FLJ78588 expression levels, mutations, or pharmacological modulators)

    • Dependent variable: The outcome you measure (e.g., signaling pathway activation, cell phenotype, or protein-protein interactions)

    • Control for extraneous variables that might influence results

  • Formulate specific, testable hypotheses based on preliminary data or structural predictions .

  • Design experimental treatments with appropriate controls:

Type of ControlPurposeExample for FLJ78588 Studies
Negative controlBaseline comparisonCells without FLJ78588 expression
Positive controlValidate assay functionWell-characterized transmembrane protein
Vehicle controlControl for treatment conditionsBuffer/solvent-only treatment
Isotype controlControl for antibody specificityNon-specific antibody of same isotype
  • Consider both between-subjects (different samples for each condition) and within-subjects (same sample under different conditions) experimental designs .

  • Use multiple complementary approaches to measure your dependent variable, such as combining biochemical assays with imaging or functional readouts.

  • Implement appropriate randomization and blinding procedures to minimize experimental bias .

What are the optimal methods for purifying functional recombinant FLJ78588?

Purification of functional transmembrane proteins presents significant challenges due to their hydrophobic nature and requirement for a lipid environment. For FLJ78588, consider this methodology:

  • Expression optimization:

    • Test multiple expression systems (E. coli, insect cells, mammalian cells)

    • Evaluate different fusion tags (His, GST, MBP) for improved solubility and yield

    • Optimize induction conditions and expression duration

  • Membrane extraction:

    • Use mild detergents for initial solubilization (DDM, LMNG, or digitonin)

    • Screen detergent panels to identify conditions that maintain functionality

    • Consider native nanodiscs or styrene maleic acid lipid particles (SMALPs) for detergent-free extraction

  • Affinity purification:

    • Implement tandem affinity purification for higher purity

    • Use size exclusion chromatography to separate protein-detergent complexes from aggregates

    • Validate protein folding using circular dichroism or fluorescence-based thermal shift assays

  • Stability assessment:

    • Monitor protein stability in different buffer compositions

    • Test stabilizing additives such as cholesterol or specific lipids

    • Assess functional activity using binding or activity assays appropriate to predicted function

The recombinant human transmembrane protein FLJ78588 has been successfully produced with a His-tag in E. coli, providing a starting point for optimization .

What mass spectrometry approaches are most effective for characterizing post-translational modifications of FLJ78588?

Mass spectrometry (MS) analysis of transmembrane proteins requires specialized approaches to overcome challenges related to hydrophobicity and low abundance. For characterizing post-translational modifications (PTMs) of FLJ78588, consider:

  • Sample preparation strategies:

    • Use complementary proteases beyond trypsin (e.g., chymotrypsin, elastase) to improve sequence coverage

    • Implement specialized enrichment methods for specific PTMs (e.g., phosphopeptide enrichment, glycopeptide capture)

    • Consider native MS approaches to preserve non-covalent interactions and conformational states

  • MS methodologies:

    • Employ high-resolution MS methods (Orbitrap, FTICR) for accurate mass determination

    • Implement hybrid fragmentation approaches (CID, HCD, ETD, EThcD) to preserve labile modifications

    • Use data-independent acquisition (DIA) for more comprehensive detection of modified peptides

  • Data analysis workflow:

    • Apply specialized search engines that account for diverse modification types and combinations

    • Validate PTM identifications using site-determining ions and localization probability scores

    • Quantify modification stoichiometry across different conditions or cellular compartments

Building on approaches used for multiregional profiling of brain transmembrane proteomes , researchers might implement deep learning models to improve identification rates for modified transmembrane peptides from FLJ78588.

How can researchers distinguish between protein-level and mRNA-level regulation of FLJ78588 expression?

Understanding the relationship between mRNA and protein expression is critical, especially for transmembrane proteins where significant discordance has been observed . To distinguish between transcriptional and post-transcriptional regulation of FLJ78588:

  • Design comprehensive profiling experiments:

    • Parallel RNA-seq and proteomics analyses from the same samples

    • Include multiple timepoints to capture dynamic regulation

    • Examine multiple tissue or cell types to identify context-specific regulation

  • Quantification approaches:

    • Implement spike-in standards for absolute quantification of both mRNA and protein

    • Use targeted approaches (qPCR, PRM/MRM) for validation of global profiling results

    • Apply regression analysis to calculate correlation coefficients between mRNA and protein levels

  • Consider data from multiple brain regions to identify discordant patterns:

Regulatory PatternInterpretationPotential Mechanisms
High mRNA, Low proteinPost-transcriptional downregulationmiRNA targeting, protein degradation
Low mRNA, High proteinPost-transcriptional upregulationIncreased translation efficiency, protein stability
Equal mRNA across regions, Region-specific proteinDifferential trafficking/localizationTransport to distant regions along projections

Studies of GPCRs in brain tissue have identified extensive discordance between mRNA and protein distribution , highlighting the importance of examining both transcriptional and post-transcriptional regulation mechanisms for transmembrane proteins like FLJ78588.

How can novel binder engineering approaches be applied to study FLJ78588?

Developing specific binders (antibodies, nanobodies, aptamers) for transmembrane proteins presents unique challenges due to their conformational complexity and limited exposed epitopes. Recent advances in binder engineering provide promising approaches for FLJ78588 research:

  • Leveraging NestLink technology for diverse binder identification:

    • This technology uses peptide barcodes (flycodes) genetically fused to binder libraries

    • Next-generation sequencing pairs each flycode with a binder molecule

    • After selection, flycodes are proteolytically released and detected via LC-MS/MS

    • This approach has shown superior performance, identifying five times more binder families compared to conventional ELISA-based screening

  • Utilizing multiple protein formulations/formats to select native epitope binders:

    • Alternating between different preparations of FLJ78588 during selection rounds

    • Incorporating the protein in nanodiscs, liposomes, and detergent micelles to present diverse conformational states

    • Implementing negative selection against denatured protein to enrich for conformation-specific binders

  • Application of emerging display technologies:

    • DNA-encoded chemical libraries for small molecule binder discovery

    • Bacterial surface display for improved membrane protein binder identification

    • Ribosome display under specialized conditions to maintain transmembrane protein folding

These approaches can generate valuable research tools for FLJ78588 characterization, enabling applications ranging from imaging to functional modulation and potential therapeutic development.

What computational approaches can predict functional domains and potential interacting partners of FLJ78588?

Computational methods offer valuable insights for transmembrane proteins like FLJ78588 where experimental data may be limited:

  • Structure prediction and domain analysis:

    • AlphaFold2 and RoseTTAFold can predict structural features with increasing accuracy for transmembrane proteins

    • Specialized transmembrane topology prediction algorithms (TMHMM, Phobius) identify membrane-spanning regions

    • Functional domain prediction through comparison with conserved domain databases

  • Protein-protein interaction prediction:

    • Co-expression analysis across tissue datasets to identify proteins with similar expression patterns

    • Interface prediction algorithms to identify potential binding sites on the protein surface

    • Text mining of literature to extract implicit relationships with other proteins

  • Functional annotation through orthology:

    • Cross-species comparison to identify conserved sequences suggesting functional importance

    • Analysis of evolutionary rate to identify constrained regions under selection pressure

    • Examination of paralogs with known functions to infer potential roles

Building on the approaches used for predicting GPCR interaction networks , researchers can apply protein coexpression analysis with stringent correlation thresholds (PCC > 0.9) to identify potential FLJ78588 interaction partners for experimental validation.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.